Pulsed Lavage in Implant-Based Breast Reconstruction

NCT ID: NCT05585710

Last Updated: 2025-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-01

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine if there is any benefit to using pulsed lavage to wash out the mastectomy pocket during breast reconstruction. Primary outcomes will include post-op complications including surgical site infection (SSI), hematoma, seroma, and implant failure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After being informed of the study including potential risks and benefits, all patients giving consent who meet eligibility requirements will undergo randomization into either the pulsed lavage arm (receive mastectomy pocket wash out using pulsed lavage) or the no pulsed lavage arm (pulsed lavage will not be used). Randomization will occur using a random number generator with even numbers resulting in a pulsed lavage washout and odd numbers resulting in no pulsed lavage washout.

The patients will be followed in clinic for a maximum of 3 months to evaluate the surgical site. The two cohorts will be compared at the end of the study to determine whether there is any benefit to using pulsed lavage to wash out the mastectomy pocket during breast reconstruction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Reconstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two cohorts will be established. One cohort will include patients who undergo pulsed lavage to wash out the mastectomy pocket. The other cohort will include patients who do not receive pulsed lavage.
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Pulsed Lavage is a surgical technique that cannot be masked from the investigators performing the operation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pulsed Lavage Washout

This cohort will undergo standard of care bilateral or unilateral mastectomies as determined by breast surgical oncologists and immediate standard of care breast reconstruction with tissue expander placement and pulsed lavage washout.

Group Type EXPERIMENTAL

Pulsed Lavage Washout

Intervention Type OTHER

Use of pressurized, pulsed triple antibiotic solution to irrigate mastectomy pocket

Implant-based breast reconstruction

Intervention Type PROCEDURE

Standard of care; use of triple antibiotic solution delivered via bulb syringes to irrigate mastectomy pocket

Bilateral or unilateral mastectomy

Intervention Type PROCEDURE

Standard of care

Tissue expander

Intervention Type DEVICE

Standard of care

Acellular dermal matrix

Intervention Type OTHER

Standard of care

No Pulsed Lavage

This cohort will undergo standard of care bilateral or unilateral mastectomies as determined by breast surgical oncologists and immediate standard of care breast reconstruction with tissue expander placement.

Group Type ACTIVE_COMPARATOR

Implant-based breast reconstruction

Intervention Type PROCEDURE

Standard of care; use of triple antibiotic solution delivered via bulb syringes to irrigate mastectomy pocket

Bilateral or unilateral mastectomy

Intervention Type PROCEDURE

Standard of care

Tissue expander

Intervention Type DEVICE

Standard of care

Acellular dermal matrix

Intervention Type OTHER

Standard of care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pulsed Lavage Washout

Use of pressurized, pulsed triple antibiotic solution to irrigate mastectomy pocket

Intervention Type OTHER

Implant-based breast reconstruction

Standard of care; use of triple antibiotic solution delivered via bulb syringes to irrigate mastectomy pocket

Intervention Type PROCEDURE

Bilateral or unilateral mastectomy

Standard of care

Intervention Type PROCEDURE

Tissue expander

Standard of care

Intervention Type DEVICE

Acellular dermal matrix

Standard of care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female
* Between 18 and 75 years of age, inclusive
* Undergoing implant-based breast reconstruction (unilateral or bilateral) with immediate expander at mastectomy
* Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document

Exclusion Criteria

* Male
* \< 18 years of age or \> 75 years of age
* Undergoing implant-based breast reconstruction (unilateral or bilateral) with delayed expander at mastectomy
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Richard Jobe Fix

Professor in the Department of Plastic Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richard J Fix, MD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ann C Braswell, BS

Role: CONTACT

256-595-3846

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ann C Braswell, BS

Role: primary

2565953846

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-300009900

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.